immunolog
characterist
sarscov
spike
protein
investig
administ
mice
plasmid
encod
variou
gene
fragment
show
secret
form
subunit
nterminu
subunit
residu
capabl
elicit
sarscov
specif
antibodi
region
immedi
nterminu
matur
protein
contain
import
immunogen
determin
elicit
sarscov
specif
antibodi
addit
mice
immun
plasmid
encod
fragment
develop
antibodi
isotyp
switch
anoth
interest
find
mous
antibodi
elicit
separ
plasmid
encod
subunit
cooper
neutral
sarscov
neither
specif
antibodi
suggest
possibl
role
subunit
host
cell
dock
entri
result
provid
insight
understand
immunolog
characterist
spike
protein
develop
subunit
vaccin
sarscov
sever
acut
respiratori
syndrom
sar
infecti
viral
diseas
caus
newli
emerg
coronaviru
sarscov
china
guangdong
unknown
origin
typic
coronalik
spike
surfac
virion
form
oligom
largest
viral
glycoprotein
name
spike
protein
protein
spike
protein
could
structur
cleav
ntermin
ctermin
subunit
translat
function
differenti
correspond
domain
without
cleavag
subunit
knob
region
spike
involv
viral
attach
cellular
receptor
henc
determin
host
cell
tropism
previou
studi
vaccin
develop
anim
coronavirus
suggest
subunit
contain
neutral
epitop
confer
protect
anim
upon
viral
challeng
subunit
stem
region
spike
coiledcoil
transmembran
region
involv
host
cell
entri
celltocel
fusion
protein
sarscov
glycoprotein
subunit
defin
highscor
align
amino
acid
sequenc
coronaviru
protein
align
conserv
domain
coronaviru
glycoprotein
sarscov
subunit
share
sever
structur
motif
wellstudi
protein
ntermin
leucineisoleucin
heptad
repeat
hr
ctermin
hr
loop
two
hr
transmembran
domain
aromat
residuerich
motif
howev
sarscov
low
sequenc
homolog
exist
anim
human
coronaviru
subunit
therefor
protein
structur
model
could
util
help
develop
vaccin
drug
recent
advanc
molecular
character
sarscov
made
genet
divers
hypervari
region
observ
anim
coronavirus
also
report
sarscov
recent
report
identifi
cellular
receptor
viru
bind
domain
defin
residu
subunit
clinic
observ
sar
patient
impli
humor
cellmedi
immun
respons
may
need
prevent
sarscov
infect
report
appar
deplet
cell
occur
earli
infect
gradual
increas
normal
level
observ
patient
recov
sarscov
specif
antibodi
detect
day
onset
symptom
kept
high
titer
least
month
recov
patient
addit
infus
convalesc
sera
patient
shown
help
diseas
recoveri
sung
et
al
unpublish
data
seroconvert
individu
ill
epidem
region
inabl
cultur
virus
rtpcr
posit
specimen
collect
patient
day
present
impli
neutral
antibodi
could
stimul
rapidli
might
restrict
viru
propag
moreov
prepar
paper
gao
et
al
report
combin
deliveri
sarscov
n
gene
macaqu
use
adenovir
vector
elicit
high
titer
neutral
antibodi
suggest
potenti
use
gene
vaccin
candid
present
studi
mice
immun
plasmid
encod
variou
gene
fragment
humor
respons
investig
result
show
antibodi
sarscov
could
induc
subunit
part
mous
antisera
could
cooper
neutral
sarscov
anim
immun
serum
collect
balbc
mice
age
week
obtain
laboratori
anim
unit
brought
anim
hous
zoolog
depart
univers
hong
kong
day
mice
anesthet
inject
lg
per
dose
plasmid
phosphatebuff
salin
pb
tibiali
anterior
ta
muscl
leg
case
coadministr
two
kind
plasmid
mous
construct
dissolv
pb
inject
ta
muscl
leg
mous
blood
regularli
collect
tail
bleed
day
sera
kept
use
day
seroconvert
group
termin
anesthet
sera
taken
assay
viru
specif
neutral
antibodi
isotyp
geometr
titer
gmt
construct
recombin
plasmid
sarscov
cdna
reversetranscrib
viral
rna
extract
sarscov
describ
previous
dna
fragment
cover
differ
region
gene
amplifi
viral
cdna
primer
proper
site
fig
show
schemat
diagram
indic
size
locat
fragment
gene
recombin
fragment
construct
join
short
fragment
overlap
extens
clone
site
bamhi
ecori
start
stop
codon
incorpor
pcr
fragment
synthes
primer
necessari
kozak
sequenc
also
ad
na
la
ahead
signal
sequenc
express
vector
pcisp
pgh
reconstruct
ad
amino
acid
residu
pig
growth
hormon
signal
peptid
sequenc
sp
pgh
upstream
modifi
polyclon
site
pci
promega
pcr
amplifi
fragment
clone
invitrogen
sequenc
describ
clone
pcisp
pgh
except
na
la
possess
signal
sequenc
gene
henc
insert
pci
fragment
nb
lb
c
f
also
clone
anoth
express
vector
invitrogen
without
signal
sequenc
plasmid
dna
fig
schemat
diagram
fulllength
sarscov
protein
deriv
fragment
use
studi
fulllength
gene
shown
immedi
hydrophob
profil
upper
signal
sequenc
gene
mark
solid
black
box
put
highli
hydrophob
region
shown
solid
box
light
grey
color
heptad
repeat
membran
span
domain
msd
indic
describ
elsewher
fragment
includ
recombin
fragment
clone
mammalian
express
vector
pcisp
pgh
except
la
na
clone
pci
fragment
nb
lb
c
f
insert
addit
construct
plasmid
use
mice
experi
differ
recombin
repres
put
hydrophil
region
use
immun
anim
prepar
plasmid
giga
kit
qiagen
valencia
ca
accord
manufactur
instruct
express
western
blot
spike
protein
test
express
gene
deriv
fragment
mammalian
cell
dna
fragment
shown
fig
clone
bamhi
ecori
site
vector
modifi
ad
iresgfp
upand
downstream
multipl
clone
site
respect
iresgfp
pcr
amplifi
plasmid
pbmnigfp
kind
gift
dr
gp
nolan
stanford
univers
school
medicin
recombin
plasmid
transfect
cell
cultur
microtit
plate
triplic
dosper
liposom
transfect
reagent
roch
mannheim
germani
follow
manufactur
instruct
express
examin
direct
observ
use
fluoresc
microscopi
express
sever
select
fragment
confirm
western
blot
transfect
cell
harvest
h
posttransfect
pt
express
protein
purifi
ni
agaros
amersham
uk
clarifi
cell
lysat
transfer
onto
pdvf
membran
biorad
hercul
ca
electroblot
sdspage
monoclon
mous
antihistag
antibodi
invitrogen
util
detect
express
protein
western
blot
elisa
test
antibodi
titer
detect
sarscov
specif
antibodi
mice
immun
gene
dna
human
antisarscov
antibodi
igg
detect
elisa
kit
beij
huada
gbi
biotechnolog
beij
china
use
accord
manufactur
instruct
except
antihuman
igg
replac
hrpconjug
goatantimous
igg
h
l
antibodi
zyme
south
san
francisco
ca
secondari
antibodi
accord
manufactur
inactiv
sarscov
viral
particl
coat
antigen
mice
group
individu
defin
seroconvert
antibodi
titer
higher
respect
gmt
individu
serum
seroconvert
group
test
end
point
dilut
sarscov
specif
mous
isotyp
detect
elisa
kit
either
hrpconjug
isotyp
monoclon
antibodi
pharmingen
use
secondari
antibodi
viru
neutral
assay
microtit
plate
contain
confluent
cell
ml
mainten
medium
fc
mem
prepar
dilut
mous
serum
ml
start
premix
ml
tcid
sarscov
strain
incub
h
ml
virusserum
mixtur
inocul
well
seed
cell
duplic
incub
cytopath
effect
cpe
examin
h
neutral
titer
determin
highest
dilut
serum
give
cpe
cell
order
investig
antigen
protein
especi
subunit
gene
segment
differ
fragment
nabc
labc
c
recombin
fragment
recombin
fragment
construct
join
variou
hydrophil
region
protein
fig
attempt
highli
express
possibl
neutral
epitop
expos
surfac
protein
fragment
insert
includ
fulllength
gene
express
cell
demonstr
observ
fluoresc
transfect
cell
data
shown
express
system
green
fluoresc
protein
gfp
encod
mrna
encod
gene
fragment
control
cmv
promot
translat
two
independ
open
read
frame
orf
although
number
fluoresc
emit
cell
densiti
fluoresc
differ
among
variou
fragment
transfect
cell
difficult
establish
connect
gfp
express
antibodi
titer
sinc
antibodi
respons
mere
influenc
directli
relat
express
antigen
addit
express
protein
also
confirm
western
blot
fig
express
differ
fragment
pcdna
detect
expect
size
howev
fail
detect
express
f
two
small
fragment
experi
although
express
proven
mrna
level
gfp
coexpress
group
sera
prepar
pool
equal
volum
individu
serum
group
sarscov
specif
antibodi
group
sera
detect
elisa
humor
respons
profil
seroconvert
group
shown
fig
individu
sera
possibl
seroconvert
group
titrat
summar
tabl
gener
could
elicit
sarscov
specif
antibodi
immunogen
import
nterminu
subunit
reveal
compar
sarscov
specif
antibodi
titer
mous
group
immun
plasmid
contain
na
nb
nc
three
fragment
share
common
region
residu
differ
nterminu
fig
higher
antibodi
titer
seroconvert
individu
observ
nb
group
na
group
nc
group
howev
show
detect
sarscov
specif
antibodi
respons
tabl
although
leader
sequenc
amino
acid
residu
nb
anoth
seri
construct
la
lb
lc
show
similar
trend
antibodi
respons
sarscov
tabl
group
immun
pcisp
pgh
contain
f
howev
show
detect
antibodi
respons
viru
c
group
show
rel
low
humor
respons
tabl
also
note
group
immun
without
signal
peptid
contain
fragment
nb
lb
c
f
show
detect
antibodi
respons
data
shown
although
express
confirm
western
blot
fig
seroconvert
sera
test
antibodi
isotyp
estim
whether
activ
mediat
antibodi
isotyp
switch
dna
immun
mice
sever
fragment
nb
lb
c
insert
pcisp
pgh
test
combin
inject
lb
signal
peptid
attach
investig
intracellular
could
activ
pathway
lead
isotyp
switch
howev
nb
lb
group
seroconvert
henc
antisera
two
group
recruit
studi
result
show
secret
form
nb
lb
could
elicit
isotyp
coadministr
addit
nonsecret
lb
group
induc
higher
ratio
group
tabl
although
nonsecret
form
protein
seem
neg
effect
antibodi
elicit
lower
group
titer
fewer
number
seroconvert
mice
observ
group
la
na
antisera
group
nb
lb
c
f
test
neutral
antibodi
titer
although
c
slightli
group
antibodi
even
detect
antibodi
respons
n
detect
antibodi
responseneutr
activ
na
applic
addit
lg
lb
dna
deliv
parallel
mous
inject
b
mix
equal
volum
two
group
mous
serum
neutral
assay
c
titer
measur
base
seroconvert
mice
group
sera
f
control
combin
seroconvert
sera
group
rest
group
use
f
elisa
assay
tabl
result
show
antiserum
combin
equal
volum
sera
group
lb
capabl
neutral
sarscov
detect
neutral
abil
observ
use
serum
sampl
includ
mix
nb
group
serum
serum
elicit
dna
cover
hydrophil
region
gene
tabl
present
studi
differ
truncat
fragment
sarscov
gene
clone
two
mammalian
express
vector
without
secret
signal
sequenc
use
immun
mice
nonsecret
form
protein
could
elicit
detect
sarscov
specif
antibodi
respons
secret
form
nterminu
n
inabl
nonsecret
protein
elicit
sarscov
specif
antibodi
may
explain
lack
express
antigen
correct
conform
expos
immun
system
posttransl
modif
includ
complex
fold
glycosyl
oligomer
occur
protein
secret
sort
wide
report
express
viral
membran
protein
differ
cellular
locat
eg
secret
membran
bound
nonsecret
form
immun
respons
dna
immun
anim
vaccin
dna
encod
secret
form
glycoprotein
classic
swine
fever
viru
csfv
show
csfv
specif
antibodi
respons
protect
upon
viral
challeng
though
nativ
anchor
membran
protein
zeng
et
al
unpublish
data
addit
shift
thelper
cell
respons
induc
express
secret
form
hemagglutinin
glycoprotein
nonsecret
form
protein
howev
might
use
activ
respons
inject
secret
nonsecret
mous
enhanc
respons
shown
rais
ratio
tabl
preliminari
data
suggest
may
possess
epitop
could
activ
tcell
respons
antibodi
neutral
antibodi
elicit
mice
experi
demonstr
sarscov
specif
antibodi
could
induc
immun
plasmid
encod
fragment
subunit
plasmid
carri
nb
residu
elicit
highest
antibodi
titer
among
seroconvert
group
tabl
residu
near
cleavag
site
signal
peptid
matur
critic
term
stimul
sarscov
specif
antibodi
demonstr
two
set
fragment
nabc
labc
express
plasmid
vector
indic
viru
neutral
assay
none
antisera
sarscov
specif
seroconvert
group
neutral
viru
instead
mix
antisera
seroconvert
group
immun
lb
plasmid
show
neutral
activ
although
concentr
antibodi
dilut
onehalf
compar
parent
sera
also
note
anoth
set
antisera
mix
sampl
nb
show
observ
neutral
activ
well
although
antibodi
titer
nb
higher
lb
serum
use
obligatori
cooper
specif
antibodi
term
viru
neutral
howev
contradict
previou
research
coronaviru
sever
author
report
immun
recombin
protein
plasmid
encod
subunit
infecti
bronchiti
viru
ibv
could
induc
protect
immun
respons
although
multipl
inocul
requir
first
paper
immun
masqu
structur
gene
sarscov
howev
report
codeliveri
three
viral
gene
encod
nucleocapsid
n
membran
protein
could
elicit
high
titer
neutral
antibodi
tcell
respons
author
state
inocul
n
could
stimul
strong
antibodi
tcell
respons
parallel
previou
experi
develop
vaccin
transmiss
gastroenter
coronaviru
tgev
togeth
experiment
data
report
hypothes
antibodi
glycoprotein
crucial
neutral
sarscov
antibodi
compon
viru
may
also
play
critic
role
viru
neutral
effect
may
becom
signific
titer
antibodi
includ
protein
low
put
cooper
role
specif
polyclon
antibodi
neutral
viru
may
serv
addit
exampl
directli
demonstr
blockag
viru
entri
bind
subunit
experi
desir
defin
exact
role
specif
polyclon
antibodi
play
neutral
sarscov
protect
abil
viru
challeng
result
describ
expect
speed
design
subunit
vaccin
immunolog
research
sarscov
